{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,7]],"date-time":"2026-07-07T21:22:18Z","timestamp":1783459338216,"version":"3.55.0"},"reference-count":19,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T00:00:00Z","timestamp":1785542400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T00:00:00Z","timestamp":1785542400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T00:00:00Z","timestamp":1785542400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T00:00:00Z","timestamp":1785542400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T00:00:00Z","timestamp":1785542400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T00:00:00Z","timestamp":1785542400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T00:00:00Z","timestamp":1785542400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100002719","name":"Aligarh Muslim University","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100002719","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","diabetesresearchclinicalpractice.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Diabetes Research and Clinical Practice"],"published-print":{"date-parts":[[2026,8]]},"DOI":"10.1016\/j.diabres.2026.113379","type":"journal-article","created":{"date-parts":[[2026,6,20]],"date-time":"2026-06-20T15:05:07Z","timestamp":1781967907000},"page":"113379","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["A study on the efficacy and safety of fosfomycin for the treatment of Multidrug-Resistant Enterobacterales urinary tract infection in North Indian type 2 diabetes mellitus patients"],"prefix":"10.1016","volume":"238","author":[{"given":"Sreemedha","family":"Choudhury","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Farhan A.","family":"Khan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8002-9142","authenticated-orcid":false,"given":"Hamid","family":"Ashraf","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fatima","family":"Khan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.diabres.2026.113379_b0005","unstructured":"World Health Organization. Health topics: Diabetes. Available from: https:\/\/www.who.int\/healthtopics\/diabetes [Accessed February 28, 2023]."},{"issue":"Suppl 1","key":"10.1016\/j.diabres.2026.113379_b0010","doi-asserted-by":"crossref","first-page":"27","DOI":"10.2174\/1874279301206010027","article-title":"Diabetes and risk of community-acquired respiratory tract infections, urinary tract infections, and bacteremia","volume":"6","author":"Thomsen","year":"2012","journal-title":"Open Infectious Dis J"},{"key":"10.1016\/j.diabres.2026.113379_b0025","first-page":"129","article-title":"Urinary tract infections in patients with type 2 diabetes mellitus: review of prevalence, diagnosis, and management","volume":"8","author":"Nitzan","year":"2015","journal-title":"Diabetes Metab Syndr Obes"},{"key":"10.1016\/j.diabres.2026.113379_b0015","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1038\/nrmicro3432","article-title":"Urinary tract infections: epidemiology, mechanisms of infection and treatment options","volume":"13","author":"Flores-Mireles","year":"2015","journal-title":"Nat Rev Microbiol"},{"key":"10.1016\/j.diabres.2026.113379_b0030","article-title":"Multidrug resistant and extensively drug resistant bacteria: a study","volume":"2016","author":"Basak","year":"2016","journal-title":"J Pathog"},{"key":"10.1016\/j.diabres.2026.113379_b0020","doi-asserted-by":"crossref","first-page":"643","DOI":"10.1086\/427507","article-title":"Infectious Diseases Society of America guidelines for the diagnosis and treatment of asymptomatic bacteriuria in adults","volume":"40","author":"Nicolle","year":"2005","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.diabres.2026.113379_b0035","doi-asserted-by":"crossref","first-page":"119","DOI":"10.4103\/ijmr.IJMR_331_18","article-title":"Antimicrobial resistance in the environment: the Indian scenario","volume":"149","author":"Taneja","year":"2019","journal-title":"Indian J Med Res"},{"key":"10.1016\/j.diabres.2026.113379_b0040","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1128\/CMR.00068-15","article-title":"Fosfomycin","volume":"29","author":"Falagas","year":"2016","journal-title":"Clin Microbiol Rev"},{"key":"10.1016\/j.diabres.2026.113379_b0045","doi-asserted-by":"crossref","first-page":"1035","DOI":"10.1517\/17425255.2011.541439","article-title":"Pharmacokinetic evaluation of fosfomycin","volume":"7","author":"Michalopoulos","year":"2011","journal-title":"Expert Opin Drug Metab Toxicol"},{"key":"10.1016\/j.diabres.2026.113379_b0050","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1016\/j.idc.2013.09.004","article-title":"Complicated urinary tract infections","volume":"28","author":"Lichtenberger","year":"2014","journal-title":"Infect Dis Clin North Am"},{"key":"10.1016\/j.diabres.2026.113379_b0055","first-page":"511","article-title":"Unusual cases in Infectious Diseases Study Group. Review of the efficacy and safety of fosfomycin trometamol in the treatment of uncomplicated urinary tract infections in diabetic patients","volume":"7","author":"Esposito","year":"2018","journal-title":"Infect Dis Ther"},{"issue":"Suppl 1","key":"10.1016\/j.diabres.2026.113379_b0060","doi-asserted-by":"crossref","first-page":"S54","DOI":"10.1016\/j.ijantimicag.2007.07.042","article-title":"Urinary tract infections in patients with diabetes mellitus: epidemiology, pathogenesis and management","volume":"31","author":"Geerlings","year":"2008","journal-title":"Int J Antimicrob Agents"},{"issue":"Suppl 1A","key":"10.1016\/j.diabres.2026.113379_b0065","doi-asserted-by":"crossref","first-page":"5S","DOI":"10.1016\/S0002-9343(02)01054-9","article-title":"Epidemiology of urinary tract infections: incidence, morbidity, and economic costs","volume":"113","author":"Foxman","year":"2002","journal-title":"Am J Med"},{"key":"10.1016\/j.diabres.2026.113379_b0070","first-page":"2013","article-title":"Sociodemographic factors and uncomplicated cystitis in women: a nationwide cohort study","volume":"100","author":"Tollingsson","year":"2021","journal-title":"Acta Obstet Gynecol Scand"},{"key":"10.1016\/j.diabres.2026.113379_b0075","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1016\/j.dsx.2021.02.003","article-title":"Achievement of guideline targets of glycemic and non-glycemic parameters in North Indian type 2 diabetes mellitus patients: a retrospective analysis","volume":"15","author":"Ashraf","year":"2021","journal-title":"Diabetes Metab Syndr"},{"key":"10.1016\/j.diabres.2026.113379_b0080","first-page":"E1003","article-title":"SGLT-2 inhibitors and the risk of serious urinary tract infections: a systematic review and meta-analysis of randomized controlled trials","volume":"190","author":"Puckrin","year":"2018","journal-title":"CMAJ"},{"key":"10.1016\/j.diabres.2026.113379_b0085","first-page":"468","article-title":"Fosfomycin in the treatment of complicated urinary tract infections: a review","volume":"51","author":"Giancola","year":"2017","journal-title":"Ann Pharmacother"},{"key":"10.1016\/j.diabres.2026.113379_b0090","doi-asserted-by":"crossref","first-page":"556","DOI":"10.1186\/s12879-016-1888-1","article-title":"Oral fosfomycin for treatment of urinary tract infection: a retrospective cohort study","volume":"16","author":"Matthews","year":"2016","journal-title":"BMC Infect Dis"},{"key":"10.1016\/j.diabres.2026.113379_b0095","article-title":"Duration of antibiotic treatment for common infections in English primary care: cross sectional analysis and comparison with guidelines","volume":"364","author":"Pouwels","year":"2019","journal-title":"BMJ"}],"container-title":["Diabetes Research and Clinical Practice"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0168822726002998?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0168822726002998?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,7,7]],"date-time":"2026-07-07T21:06:37Z","timestamp":1783458397000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0168822726002998"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,8]]},"references-count":19,"alternative-id":["S0168822726002998"],"URL":"https:\/\/doi.org\/10.1016\/j.diabres.2026.113379","relation":{},"ISSN":["0168-8227"],"issn-type":[{"value":"0168-8227","type":"print"}],"subject":[],"published":{"date-parts":[[2026,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"A study on the efficacy and safety of fosfomycin for the treatment of Multidrug-Resistant Enterobacterales urinary tract infection in North Indian type 2 diabetes mellitus patients","name":"articletitle","label":"Article Title"},{"value":"Diabetes Research and Clinical Practice","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.diabres.2026.113379","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Elsevier B.V. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"113379"}}